+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Liver And Kidney Disorders Drugs Market Research Reports

From
Chronic Kidney Disease Market Report 2025 - Product Thumbnail Image

Chronic Kidney Disease Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Diabetic Kidney Disease Market Report 2025 - Product Thumbnail Image

Diabetic Kidney Disease Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
From
From
Non-Alcoholic Steatohepatitis Market 2025-2033 - Product Thumbnail Image

Non-Alcoholic Steatohepatitis Market 2025-2033

  • Report
  • March 2025
  • 142 Pages
  • Global
From
From
From
Liver Disease Diagnostics Market Report 2025 - Product Thumbnail Image

Liver Disease Diagnostics Market Report 2025

  • Report
  • April 2025
  • 175 Pages
  • Global
From
From
From
From
From
Non-Structural Protein 5 Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

Non-Structural Protein 5 Inhibitor - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 90 Pages
  • Global
From
Complement 3 Glomerulopathy - Pipeline Insight, 2025 - Product Thumbnail Image

Complement 3 Glomerulopathy - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Renal Cell Carcinoma - Pipeline Insight, 2025 - Product Thumbnail Image

Renal Cell Carcinoma - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Angelman Syndrome- Pipeline Insight, 2025 - Product Thumbnail Image

Angelman Syndrome- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Minimal Change Disease - Pipeline Insight, 2025 - Product Thumbnail Image

Minimal Change Disease - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 40 Pages
  • Global
From
Hepatorenal Syndrome - Pipeline Insight, 2025 - Product Thumbnail Image

Hepatorenal Syndrome - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Loading Indicator

The Liver and Kidney Disorders Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs to treat diseases and disorders of the liver and kidneys. These drugs are used to treat a variety of conditions, including hepatitis, cirrhosis, kidney failure, and other kidney-related diseases. The market is highly competitive, with many companies vying for market share. The market is driven by the increasing prevalence of liver and kidney diseases, as well as the development of new treatments and technologies. Additionally, the rising demand for better treatments and the increasing availability of generic drugs are also contributing to the growth of the market. Some of the major companies in the Liver and Kidney Disorders Drugs market include Pfizer, Merck, Novartis, Sanofi, GlaxoSmithKline, AstraZeneca, Bristol-Myers Squibb, and AbbVie. These companies are engaged in the development and production of drugs to treat liver and kidney diseases. Show Less Read more